NO308396B1 - FremgangsmÕte ved fremstilling av substanser av polypeptidnatur - Google Patents

FremgangsmÕte ved fremstilling av substanser av polypeptidnatur

Info

Publication number
NO308396B1
NO308396B1 NO932101A NO932101A NO308396B1 NO 308396 B1 NO308396 B1 NO 308396B1 NO 932101 A NO932101 A NO 932101A NO 932101 A NO932101 A NO 932101A NO 308396 B1 NO308396 B1 NO 308396B1
Authority
NO
Norway
Prior art keywords
substances
administered
polypeptide nature
preparation
hclo4
Prior art date
Application number
NO932101A
Other languages
English (en)
Norwegian (no)
Other versions
NO932101L (no
NO932101D0 (no
Inventor
Alberto Bartorelli
Angela Turiano
Original Assignee
Zetesis Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zetesis Spa filed Critical Zetesis Spa
Publication of NO932101D0 publication Critical patent/NO932101D0/no
Publication of NO932101L publication Critical patent/NO932101L/no
Publication of NO308396B1 publication Critical patent/NO308396B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2/00—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO932101A 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur NO308396B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT02234190A IT1244879B (it) 1990-12-11 1990-12-11 Estratti da tessuti animali, utili in terapia e in diagnostica.
PCT/EP1991/002354 WO1992010197A1 (en) 1990-12-11 1991-12-09 Substances of polypeptide nature useful in human therapy

Publications (3)

Publication Number Publication Date
NO932101D0 NO932101D0 (no) 1993-06-09
NO932101L NO932101L (no) 1993-08-10
NO308396B1 true NO308396B1 (no) 2000-09-11

Family

ID=11194931

Family Applications (1)

Application Number Title Priority Date Filing Date
NO932101A NO308396B1 (no) 1990-12-11 1993-06-09 FremgangsmÕte ved fremstilling av substanser av polypeptidnatur

Country Status (16)

Country Link
US (1) US5824640A (it)
EP (1) EP0574394B1 (it)
JP (1) JP3213942B2 (it)
KR (1) KR100196028B1 (it)
AT (1) ATE122890T1 (it)
AU (1) AU661287B2 (it)
CA (1) CA2098113C (it)
CZ (1) CZ283037B6 (it)
DE (1) DE69110060T2 (it)
DK (1) DK0574394T3 (it)
ES (1) ES2073277T3 (it)
HU (1) HU217615B (it)
IT (1) IT1244879B (it)
NO (1) NO308396B1 (it)
RU (1) RU2113224C1 (it)
WO (1) WO1992010197A1 (it)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA27048C2 (uk) * 1993-10-18 2000-02-28 Центр Ембріональних Тканин "Емселл" Лікарський препарат імуhокоригуючої дії hа осhові клітиhhої суспеhзії, спосіб лікуваhhя цукрового діабету з використаhhям цього препарату
IT1270618B (it) * 1994-07-14 1997-05-07 Zetesis Spa Proteine ad attivita' antitumorale
IT1276860B1 (it) * 1994-11-04 1997-11-03 Zetesis Spa Anticorpi naturali contro proteine allogeniche e xenogeniche e metodi per la loro determinazione
PL188137B1 (pl) * 1995-02-03 2004-12-31 Aeterna Lab Inc Zastosowanie wyciągu z chrząstki rekina
IT1276707B1 (it) * 1995-06-13 1997-11-03 Zetesis Spa Composizioni farmaceutiche ad attivita' analgesica
IT1282608B1 (it) * 1996-02-13 1998-03-31 Zetesis Spa Sequenza oligonocleotidica da fegato di capra
IT1284524B1 (it) * 1996-09-13 1998-05-21 Zetesis Spa Uso di proteine come agenti anti-retrovirali
CZ293926B6 (cs) * 1996-09-18 2004-08-18 Zetesisás@Áp@Áa Farmaceutický prostředek
IT1298442B1 (it) * 1998-02-24 2000-01-10 Zetesis Spa Composizioni orali a basso dosaggio di proteine citotossiche
US20030165492A1 (en) * 2000-06-08 2003-09-04 Alberto Panerai Method of treatment of alzheimer's disease with a protein extractable from mammalian organs
AU2001262340A1 (en) * 2000-06-08 2001-12-17 Rakepoll Holding B.V. A method of treatment of parkinson's disease with a protein extractable from mammalian organs
AU2001278436A1 (en) * 2000-06-08 2001-12-17 Rakepoll Holding B.V. A method of treatment of amyotrophic lateral sclerosis with a protein extractable from mammalian organs
US20030153511A1 (en) * 2000-06-08 2003-08-14 Alberto Panerai Method of treatment of huntington's chorea with a protein extractable from mammalian organs
ITMI20010762A1 (it) * 2001-04-10 2002-10-10 Zetesis Spa Uso della proteina uk114 o di suoi frammenti per il trattamento e la prevenzione dello shock endotossico
RU2211700C2 (ru) * 2001-07-23 2003-09-10 Научно-исследовательский институт медико-биологических проблем Республики Северная Осетия-Алания Способ получения лекарственного препарата "скваакан"
ITMI20022307A1 (it) * 2002-10-30 2004-04-30 Zetesis Spa Associazioni anti-tumorali comprendenti proteine e chemioterapici.
RU2390353C2 (ru) * 2004-02-12 2010-05-27 Мерк Патент Гмбх Высококонцентрированные жидкие композиции анти-egfr антител
RU2292393C2 (ru) * 2005-03-03 2007-01-27 Закрытое акционерное общество "Научно-производственное предприятие "Тринита" Способ получения ингибитора коллагеназы из гепатопанкреаса промысловых видов краба

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1598811A (en) * 1977-01-12 1981-09-23 Hoffmann La Roche Carcinoma-associated antigens
US4818763A (en) * 1984-01-12 1989-04-04 Volker Rusch Biologically active substance with hormonal properties, production process thereof and utilization of histones for medical purposes
JPH064675B2 (ja) * 1985-07-29 1994-01-19 伝一 水野 抗腫瘍性ポリペプチド

Also Published As

Publication number Publication date
IT1244879B (it) 1994-09-12
HU217615B (hu) 2000-03-28
RU2113224C1 (ru) 1998-06-20
CZ283037B6 (cs) 1997-12-17
DK0574394T3 (da) 1995-10-16
CA2098113C (en) 2002-02-05
ES2073277T3 (es) 1995-08-01
IT9022341A0 (it) 1990-12-11
HUT64569A (en) 1994-01-28
KR100196028B1 (ko) 1999-06-15
NO932101L (no) 1993-08-10
NO932101D0 (no) 1993-06-09
EP0574394B1 (en) 1995-05-24
CA2098113A1 (en) 1992-06-11
AU661287B2 (en) 1995-07-20
ATE122890T1 (de) 1995-06-15
DE69110060D1 (de) 1995-06-29
CZ111693A3 (en) 1994-04-13
EP0574394A1 (en) 1993-12-22
AU9035791A (en) 1992-07-08
JPH06504039A (ja) 1994-05-12
IT9022341A1 (it) 1992-06-11
DE69110060T2 (de) 1995-09-28
JP3213942B2 (ja) 2001-10-02
US5824640A (en) 1998-10-20
WO1992010197A1 (en) 1992-06-25
HU9301677D0 (en) 1993-09-28

Similar Documents

Publication Publication Date Title
NO308396B1 (no) FremgangsmÕte ved fremstilling av substanser av polypeptidnatur
DE69738754D1 (de) Hemmer der interaktion zwischen p53 und mdm2
TW428026B (en) Bifunctional protein, preparation and use
DK0584266T3 (da) Rekombinant virus udtrykkende carcinoembryonalt antigen og fremgangsmåder til anvendelse heraf
BR9808881A (pt) Compostos para imunoterapia de câncer de próstata e métodos para seu uso
RU95110767A (ru) Днк, кодирующая гликопротеин человеческого происхождения
DE69733834D1 (de) Thyroxin-analoge mit keiner signifikanten hormonellen aktivität zur behandlung von bösartigen tumoren
EA199800391A1 (ru) Ингибирование роста опухоли антисмысловыми олигонуклеотидами к il-8 и il-8 рецептору
ATE329030T1 (de) Nukleinsäure, welche einen von lektin abstammenden faktor zur präservierung von progenitorzellen kodiert
NZ309659A (en) Composition comprising LbeIF4A and/or LmeIF4A polypeptides (Leishmania antigen) and methods for enhancing immune responses
IT8148663A0 (it) Linea di cellule derivate da epato ma umano per studi metabolici coltivazione di virus e preparazione di vaccini e procedimento di preparazione
RU93042874A (ru) Соединения полипептидной природы, способ их получения, композиция на их основе, их применение в противоопухолевой терапии
ATE433461T1 (de) Rana pipiens proteine und deren verwendung in der behandlung von tumoren
ATE187493T1 (de) Gp75 als tumorimpfstoff gegen melanome
ES2141249T3 (es) Procedimiento para la identificacion de celulas humanas y animales que presentan la capacidad para una proliferacion ilimitada o para una formacion de tumores.
BR9609026A (pt) Composição processo para o tratamento do cáncer e de detecção para a produção de citicina por tumores para determinar a eficácia de um autólogo e kit diagnóstico para detecção para eficácia de compostos celulares autólogos
RU98118574A (ru) Метод уничтожения нежелательных клеток-мишеней
BG101038A (bg) Супресия на растежа на туморни клетки посредствомсиндекан- 1 ектоучастък
PT951553E (pt) Proteinas de e4 de adenovirus para unducao de morte celular
RU94045930A (ru) Белки, днк, вектор, клетка, способы получения и очистки белка, фармацевтическая композиция
Shi et al. Proteomic detection of changes in protein synthesis induced by lanthanum in BGC-823 human gastric cancer cells
EP1317470A4 (en) ANTISENSE OLIGODESOXYNUCLEOTIDES, INSULINOID GROWTH FACTOR 2 (IGFBP-2) PROTEINS FOR THE TREATMENT OF PROSTATE CANCER AND OTHER ENDOCRINE TUMORS
AU6987696A (en) The use of the wap of mmtv regulatory sequences for targeted expression of linked heterologous genes in human mammary cells, including human mammary carcinoma cells
Castiglioni et al. First results of tissue culture in Drosophila
RU95101019A (ru) Способ получения фактора некроза опухоли, фактор некроза опухоли, днк, клетка, композиция

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees